BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 17, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Washington roundup: Yale; Infuse better than graft; cancer data are 'inconclusive'

July 1, 2013
By Mark McCarty

Deals roundup: Bard to sell Electrophysiology unit to Boston Sci for $275M

July 1, 2013
By Omar Ford

Agreements/contracts: Zecotek collaborates with IV on IP strategy programs

July 1, 2013

HIT roundup: McKesson Pharmacy releases a mobile delivery application

July 1, 2013

Product Briefs

July 1, 2013

Med-Tech Notes

July 1, 2013

MDD's Neurology Extra

July 1, 2013

Multicenter study to evaluate HeartLight for persistent AF

July 1, 2013
By Omar Ford
CardioFocus (Marlborough, Massachusetts), a developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), said that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF.
Read More

I've got 99 problems but a CT scan isn't one of 'em

June 28, 2013
By Omar Ford
As a proud father of a two-year-old little girl, it's always stories the stories about children that grab my attention the most. Take for instance, a recent one that I wrote, discussing the risk of radiation-induced solid cancers in older children. The story comes from a study published in the journal JAMA Pediatrics and possible appendicitis was cited as a leading cause of abdominal/pelvic CT usage. The first question I asked myself, one that I had never asked before... was if I should be overly concerned if my daughter needs a CT scan. The good news is, one med-tech company...
Read More

Double trouble: Two firms under FDA’s microscope

June 28, 2013
By Mark McCarty
A lot of warning letters and other FDA enforcement action are addressed to obscure companies, but lately a few big names have come under scrutiny. In a recent posting here at MDD Perspectives, we addressed a warning letter to Edwards Lifesciences, but they’re not the only big name to show up behind the FDA woodshed. Is this a trend or mere chance? I’ll let you decide. FDA recently posted the 483 from an inspection of Intuitive Surgical of Sunnyvale, California, which is not unheard of, but is not...
Read More
Previous 1 2 … 3511 3512 3513 3514 3515 3516 3517 3518 3519 … 10254 10255 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing